Company Filing History:
1 out of 5 
1 out of 74 
1 out of 11 
Years Active: 2021
Title: Innovations in Cancer Treatment by Gemma Quincoces Fernández
Introduction
Gemma Quincoces Fernández is a prominent inventor based in Navarra, Spain. She has made significant contributions to the field of medicine, particularly in the treatment of cancer and ocular diseases. Her innovative approach involves the use of albumin nanoparticles, which have the potential to revolutionize therapeutic methods.
Latest Patents
Gemma holds a patent for "Albumin nanoparticles for the treatment of cancer and ocular diseases." This invention refers to nanoparticles that comprise a core made of a non-crosslinked albumin matrix and a monoclonal antibody. The nanoparticles may also be coated with a non-ionic polymer for use as a medicament. This pharmaceutical composition is designed for the treatment of cancer and ocular diseases, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Gemma has worked with esteemed institutions such as the Universidad Nacional de Córdoba and the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). Her work in these organizations has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Daniel Alberto Allemandi and Carolina Boiero. Their collaborative efforts have further enhanced the impact of her research and innovations.
Conclusion
Gemma Quincoces Fernández is a trailblazer in the field of medical innovation, particularly in cancer treatment. Her work with albumin nanoparticles represents a significant advancement in therapeutic options, and her collaborations with esteemed institutions and colleagues highlight her dedication to improving healthcare outcomes.